Accordingly, a recent study showed that the expression levels of the ketone body-metabolizing enzymes succinyl-CoA 3-oxoacid CoA transferase (OXCT1) and 3-hydroxybutyrate dehydrogenase 1 (BDH1) are reduced in glioma tissue (37). The gene discussed is OXCT1; the disease is central nervous system cancer.